UPDATE 1-Safety data on AstraZeneca anaemia drug points to potential use in dialysis
November 08, 2019 at 14:52 PM EST
AstraZeneca said that safety data on roxadustat underpinned the British drugmaker's hopes for the anaemia drug to become a standard treatment for patients with kidney disease.
